Global CannaVigilance Cannabis Newsletter 2022 / 3

February 02, 2022 | Category : Global CannaVigilance | Posted By : Team Cannavigia

Hello friends of CannaVigilance,

First things first: We are now a proud partner of the industry association Cannabiswirtschaft e.V. The association is the voice of the cannabis industry in Germany and bundles industry-political, technological and economic expertise and advocates for better political framework conditions. As a member of the association, we actively share our suggestions and proposals and aim to increase market interest and jointly shape the future of the cannabis industry.   
Not only do we share our knowledge in the recently joined industry assocation, but also on several events and panels:

Good news from Thailand  

Cannavigia’s CEO, Luc Richner, joined industry leaders Tim Oates and Tom Julpas Kruesopon on Plug and Play Thailand’s monthly AgTech panel on the topic of Hemptech last week. The various challenges and opportunities for the Asian Hemp and CBD industry were discussed, from the role of smallholder farmers to an evaluation of the potential success of recreational cannabis versus medical CBD. Advice was given to entrepreneurs looking to navigate the challenges of the industry including high barriers to entry, in particular large capital and knowledge requirements, as well as the need for traceability and regulation to ensure compliance with international standards, especially when pharmaceutical products are concerned. Overall, what can be agreed is that while the dynamics of the legalization of marijuana in Thailand won’t be the same as in the United States, the potential is huge for those with the right tools and resources in place. 
You want to share your thoughts on the dynamics of the legalization of marijuana in Thailand – hit us up on LinkedIn or contact our CEO Luc Richner:

See you soon in Zurich?  

The Cannabis Business Club Switzerland has shared the date for their next event: On 14 April, the experts of the cannabis industry come together and talk about the latest developments in the industry. The possible legalization in Germany, medical cannabis from and in Switzerland and pilot projects in Europe are just a few of the interesting topics that we will be discussed. We would love to see you there – sign up here.  

News Update 

If you can’t wait to hear what is happening in the cannabis industry around the globe, we have summarized the most important news for you:  

It was quite the week.

It was revealed that excise taxes for marijuana sold for adult recreational use exceeded alcohol excise taxes for the first time in Massachusetts and an ancient Chinese warrior from the Tang dynasty was discovered to have cannabis in his tomb. Here’s more news below: 

France bans flowers 

In a New Year’s blow to French growers, the government banned the sale of CBD flowers outright. The government claimed that the ban was to help to police as “it was impossible for them to tell if it was a legal or illegal version”. The decision was reversed by the highest court in the country on 26 January, after which the Interior Minister Gérald Darmanin told France Inter radio that he “regretted” the court’s decision. “All substances that are related to cannabis, drugs, are very bad for your health,” he said. “We have not increased the price of tobacco to 10 euros to accept the legalisation or decriminalisation of cannabis.” 

The East shall rise 

After South Korea became the first country in East Asia to legalise the use of medical cannabis, other Asian countries are slowly opening up as well. The media in India is increasingly writing positive pieces about cannabis, tying it to medicinal, religious and historic backgrounds. Thailand, the first country in Southeast Asia to allow medicinal cannabis, recently started discussion about removing cannabis from their list of narcotics. The smokers celebrated like it already happened. Under the new rule, people can grow cannabis plants at home after notifying their local government, but the cannabis cannot be used for commercial purposes (more info here).  

Newsletter Sign-up